Joseph Cook

JOSEPH COOK, JR. has been Chairman of the Board and Chief Executive
Officer of Amylin Pharmaceuticals, Inc. since March 1998. Prior to such
time, he had served as a Board member and a consultant to the company
since 1994. Mr. Cook is also a Director of Dura Pharmaceuticals, Inc., a
specialty respiratory pharmaceutical and pulmonary drug delivery
company, and Nabi, a research- and development-driven biopharmaceutical
company that makes and markets products for people with life-threatening
conditions. Mr. Cook is a founder and serves as Chairman of the Board of
Microbia, Inc., a privately held biotechnology company. Mr. Cook is also
a founder of Clinical Products, Ltd., Life Science Advisors, LLC,
Cambrian Associates, LLC, and Mountain Ventures, Inc. Mr. Cook retired
as a Group Vice President of Eli Lilly and Company in 1993 after more
than 28 years of service. Mr. Cook received a BS in Engineering from the
University of Tennessee.